TELL : +91 0 99 08 87 07 06

 Mcmed International ®: Largest Journal Publication in world

Acta Biomedica Scientia

Volume 4, Issue 3, 2017
Mcmed International
Acta Biomedica Scientia
Issn
2348 - 215X (Print), 2348 - 2168 (Online)
Frequency
bi-annual
Email
editorabs@mcmed.us
Journal Home page
http://mcmed.us/journal/abs
Recommend to
Purchase
Abstract
Title
EVALUATE THE EFFICACY OF INTRAVITREAL CONBERCEPT INJECTIONS IN NON-PROLIFERATIVE DIABETIC RETINOPATHY IN A TERTIARY CARE
Author
Dr.P.Krishna murthy Choudary1* & Dr.Hari Priya2
Email
saravanacology@gmail.com
keyword
Conbercept, Patient characteristics, Diabetic retinopathy
Abstract
To date, few effective treatments have been offered. Pan retinal photocoagulation is the preferred treatment option for the treatment of critical NPDR. This approach, however, will maintain visual acuity only and could be interfering with other sight skills; also, the assessment of recurrence after therapy maintains huge. As a result, the development of local NPDR therapy is important to prevent the disease from progressing to a point where it may have a significant impact on visual acuity. The purpose of this study was to determine how intravitreal conbercept injections work in non-proliferative diabetic retinopathy. The study included patients with type 2 diabetes, medication-controlled blood sugar levels, glycosylated hemoglobin levels below 10 percent, then BP below 160/90 mmHg, respectively. The research comprised a total of 54 individuals with NPDR. A total of 54 eyes were chosen from the 54 patients, including 30 right eyes and 24 left eyes. For diabetic retinopathy, anti-VEGF medication has lately become a prominent therapeutic choice. Anti-VEGF injections into the eyes have been used to treat vision-threatening diseases. This vision-saving procedure is especially beneficial to patients with diabetic retinopathy. In afflicted individuals, intravitreal conbercept injection exhibited a clear and persistent therapeutic effect on NPDR, according to our data. However, a more thorough investigation of the therapeutic mechanism is needed.
Back to Top >>>>